Structure |
Chemical Name |
CAS |
MF |
|
5-(4-aMino-1-isopropyl-1H-pyrazolo[3,4-d]pyriMidin-3-yl)benzo[d]oxazol-2-aMine |
1224844-38-5 |
C15H15N7O |
|
ZOTAROLIMUS |
221877-54-9 |
C52H79N5O12 |
|
N-Ethyl-N'-[4-[5,6,7,8-tetrahydro-4-[(3S)-3-methyl-4-morpholinyl]-7-(3-oxetanyl)pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea |
1207360-89-1 |
C24H32N6O3 |
|
9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one |
1223001-51-1 |
C24H15F3N4O |
|
Torin 1 |
1222998-36-8 |
C35H28F3N5O2 |
|
WYE-354 |
1062169-56-5 |
C24H29N7O5 |
|
N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea |
1144068-46-1 |
C27H33N7O4 |
|
Alizapride hydrochloride |
59338-87-3 |
C16H22ClN5O2 |
|
3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol |
677297-51-7 |
C18H14N6O2 |
|
PIK-294 |
900185-02-6 |
C28H23N7O2 |
|
PIK-75 Hydrochloride |
372196-77-5 |
C16H15BrClN5O4S |
|
PKI-402 |
1173204-81-3 |
C29H34N10O3 |
|
XL765 |
1349796-36-6 |
C31H29N5O6S |
|
5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione |
958852-01-2 |
C18H11N3O2S |
|
VS-5584 |
1246560-33-7 |
C17H22N8O |
|
CZC24832 |
1159824-67-5 |
C15H17FN6O2S |
|
A66 |
1166227-08-2 |
C17H23N5O2S2 |
|
NVP-BGT226 |
1245537-68-1 |
C28H25F3N6O2.C4H4O4 |
|
CH5132799 |
1007207-67-1 |
C15H19N7O3S |
|
AVL-292 |
1202757-89-8 |
C22H22FN5O3 |
|
LY310762 |
192927-92-7 |
C24H27O2N2FHCl |
|
LY 2874455 |
1254473-64-7 |
C21H19Cl2N5O2 |
|
5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
475488-23-4 |
C28H31N5O |
|
OSI-420 |
183320-51-6 |
C21H22ClN3O4 |
|
VU 0357121 |
433967-28-3 |
C17H17F2NO2 |
|
Ciproxifan |
184025-18-1 |
C16H18N2O2 |
|
BRL 54443 |
57477-39-1 |
C14H18N2O |
|
AVP-AEW541 |
475489-16-8 |
C27H29N5O |
|
Dexmedetomidine |
113775-47-6 |
C13H16N2 |
|
AMG-208 |
1002304-34-8 |
C22H17N5O2 |
|
KRN 633 |
286370-15-8 |
C20H21ClN4O4 |
|
R428 |
1037624-75-1 |
C30H34N8 |
|
CP-724714 |
537705-08-1 |
C27H27N5O3 |
|
BAY 80-6946 (Copanlisib) |
1032568-63-0 |
C23H28N8O4 |
|
BRL 15572 HYDROCHLORIDE |
193611-72-2 |
C25H28Cl2N2O |
|
NVP-BVU 972 |
1185763-69-2 |
C20H16N6 |
|
(-)-MK-801 MALEATE |
121917-57-5 |
C20H19NO4 |
|
TYRPHOSTIN AG 1024 |
65678-07-1 |
C14H13BrN2O |
|
AS 604850 |
648449-76-7 |
C11H5F2NO4S |
|
Ziprasidone |
122883-93-6 |
C21H21ClN4OS |
|
AMG 458 |
913376-83-7 |
C30H29N5O5 |
|
N-(4-Chloro-3-methoxyphenyl)-2-pyridinecarboxamide |
1161205-04-4 |
C13H11ClN2O2 |
|
IGF-1R Inhibitor II, N-(5-Chloro-2-methoxyphenyl)-Nμ-(2-methylquinolin-4-yl)urea |
196868-63-0 |
C18H16ClN3O2 |
|
2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid |
1173900-33-8 |
C22H24N4O4 |
|
5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine |
870483-87-7 |
C20H22N4O3 |
|
1-{2-[5-(2-Methoxy-ethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine |
343787-29-1 |
C24H27N5O2 |
|
NVP-BHG712 |
940310-85-0 |
C26H20F3N7O |
|
TAK-285 |
871026-44-7 |
C26H25ClF3N5O3 |
|
MGluR5 inhibitor |
871362-31-1 |
C19H13ClF3N3O |
|
JNJ7777120 |
459168-41-3 |
C14H16ClN3O |
|
4-(4-FLUORO-1-NAPHTHALENYL)-6-(1-METHYLETHYL)-2-PYRIMIDINAMINE HYDROCHLORIDE |
199864-87-4 |
C17H16FN3 |
|
LY-404039 |
635318-11-5 |
C7H9NO6S |
|
Capmatinib |
1029712-80-8 |
C23H17FN6O |
|
4-(Diphenylmethylen)-1,1-dimethyl-piperidinium-methyl-sulfat |
62-97-5 |
C20H24N.CH3O4S |
|
BMS-754807 |
1001350-96-4 |
C23H24FN9O |
|
Tie2 kinase inhibitor |
948557-43-5 |
C26H21N3O2S |
|
BMS-794833 |
1174046-72-0 |
C23H15ClF2N4O3 |
|
Lorlatinib |
1454846-35-5 |
C21H19FN6O2 |
|
LRRK2-IN-1 |
1234480-84-2 |
C31H38N8O3 |
|
ARRY-334543 |
845272-21-1 |
C22H19ClN6O2S |
|
Golvatinib (E7050) |
928037-13-2 |
C33H37F2N7O4 |
|
2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-1H-IMIDAZOLE |
189224-48-4 |
C13H14N2O |
|
Mk-2461 . |
917879-39-1 |
C24H25N5O5S |
|
WZ8040 |
1214265-57-2 |
C24H25ClN6OS |
|
Insulin-like Growth Factor-1 Receptor Inhibitor |
468740-43-4 |
C25H26ClN5O3 |
|
SR 1078 |
1246525-60-9 |
C17H10F9NO2 |
|
AST-1306 |
1050500-29-2 |
C31H26ClFN4O5S |
|
Poziotinib (HM781-36B) |
1092364-38-9 |
C23H21Cl2FN4O3 |
|
ALK/IGF1R inhibitor |
1356962-20-3 |
C24H25ClN6O |
|
ZM 306416 |
690206-97-4 |
C16H13ClFN3O2 |
|
3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon |
194413-58-6 |
C15H14N2O |
|
lenvatinib Mesylate |
857890-39-2 |
C22H23ClN4O7S |
|
OSI-930 |
728033-96-3 |
C22H16F3N3O2S |
|
UNC2881 |
1493764-08-1 |
C25H33N7O2 |
|
REVERSINE |
656820-32-5 |
C21H27N7O |
|
SB269970 HCl |
261901-57-9 |
C18H28N2O3SHCl |
|
PD153035 HCl |
183322-45-4 |
C16H14BrN3O2.HCl |
|
ARRY-380 |
937265-83-3 |
C29H27N7O4S |
|
NVP-BSK805 |
1092499-93-8 |
C27H28F2N6O |
|
3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-N-(2-pyridinylmethyl)-5H-benzo[4,5]cyclohepta[1,2-b]pyridine-7-methanesulfonamide |
1001917-37-8 |
C25H21N5O3S |
|
N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine |
1097917-15-1 |
C29H40N8O3S |
|
E-3810 |
1058137-23-7 |
C26H25N3O4 |
|
DCC-2618 |
1225278-16-9 |
C26H21F2N5O3 |
|
GNF 5837 |
1033769-28-6 |
C28H21F4N5O2 |
|
ANA12 |
219766-25-3 |
C22H21N3O3S |
|
Tepotinib |
1100598-32-0 |
C29H28N6O2 |
|
GSK1838705A |
1116235-97-2 |
C27H29FN8O3 |
|
3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione |
905854-02-6 |
C23H19N3O2 |
|
WZ3146 |
1214265-56-1 |
C24H25ClN6O2 |
|
GDC-0941 Bimesylate |
957054-33-0 |
C24H30N7O6S3 |
|
Icotinib |
610798-31-7 |
C22H21N3O4 |
|
UNC2250 |
1493694-70-4 |
C24H36N6O2 |
|
PD168393 |
194423-15-9 |
C17H13BrN4O |
|
Sb-742457 |
607742-69-8 |
C19H19N3O2S |
|
2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]- |
194423-06-8 |
C18H13BrN4O |
|
VUF 10166 |
155584-74-0 |
C13H15ClN4 |
|
SAR 131675 |
1433953-83-3 |
C18H22N4O4 |
|
ZM 323881 hydrochloride |
193000-39-4 |
C22H19ClFN3O2 |
|
CNX-2006 |
1375465-09-0 |
C26H27F4N7O2 |
|
SKLB1002 |
1225451-84-2 |
C13H12N4O2S2 |